DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre

Size: px
Start display at page:

Download "DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre"

Transcription

1 DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre JAPC has classified Freestyle Libre as BROWN after diabetes consultant/specialist initiation within a Derbyshire diabetes service*. The criteria and process below must be strictly adhered to. Identification Consultant identifies those with Type 1 diabetes aged four and above on intensive insulin therapy meeting RMOC criteria: Patients who undertake intensive blood glucose monitoring 8 times daily (confirm with Diasend download) Those who meet the current NICE criteria for insulin pump therapy (HbA1c 8.5%, 69.4mmol/mol) or disabling hypoglycaemia as described in NICE TA151) where a successful trial of FreeStyle Libre may avoid the need for pump therapy (has attended structured education and is monitoring glucose 4/day) Those who have recently developed impaired awareness of hypoglycaemia (Gold score 4) Frequent admissions (>2 per year) with DKA or hypoglycaemia. Those who require third parties to carry out monitoring and where conventional blood testing is not possible Baseline clinical data Complete baseline FreeStyle Libre Audit form ( documenting reason for initiation. Ensure recent HbA1c available Consultant referral for Freestyle Libre initiation Freestyle Libre Education Session Contract for Freestyle Libre use completed Person with diabetes attends FreeStyle Libre education session Provided with FreeStyle Libre starter kit of reader and 1 sensor (a sensor lasts 14 days) Ensure baseline data collected and HbA1c available from within past 2 months GP prescription request FreeStyle Libre proforma completed to request GP prescription only if baseline HbA1c available, audit data captured, reason for initiation clearly documented and person with diabetes attends education session. If any of above missing, delay initiation until complete. Follow up data collection Consultant responsible for the patient must ensure follow up audit data is captured within 6 months of initiation. Consultant must document clinical benefit (e.g. fall in HbA1c by 0.5% or a reduction in hypoglycaemia or a reduced frequency of admissions or reversal of hypoglycaemia unawareness or improved quality of life); stop prescription if no benefit or DNA 1 year audit At 3 monthls JAPC monitors uptake 6-12 months diabetes service review audit data with JAPC * Permitted for NHS patients started outside of Derbyshire that comply with RMOC criteria and undertaking the national audit or following an APC shared care agreement Freestyle Libre JAPC briefing Page 1 of 7

2 Existing patients Patients currently self-funding FreeStyle Libre will only be prescribed the device on the NHS if the above criteria (same as new patients) have been met. Useful Links Regional Medicines Optimisation Committee (RMOC) Flash Glucose Monitoring Systems Position Statement Association of Children s Diabetes Clinicians (ACDC) Information to help a formulary case for Freestyle Libre system for use in children, young people and adults with diabetes Appendix 1 ABCD Nationwide FreeStyle Libre Audit Form- Initiation (First visit) Freestyle Libre JAPC briefing Page 2 of 7

3 Page 3 of 7

4 Page 4 of 7

5 Page 5 of 7

6 Appendix 2 ABCD Nationwide FreeStyle Libre Audit Form- Follow up visit Freestyle Libre JAPC briefing Page 6 of 7

7 Page 7 of 7

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults NHS Leeds CCG Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults Produced by: Jo Alldred, Medicines Effectiveness Lead, NHS Leeds CCG Dr Bryan Power, Long Term Conditions

More information

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system The Freestyle Libre flash glucose monitoring system is a sensor based, factory-calibrated system that measures interstitial fluid

More information

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018 Technology Commissioning Statement Flash Glucose Monitoring system (FreeStyle Libre ) March 2018 FreeStyle Libre (Abbott) Flash Glucose Monitoring System for use in adults, young people and children. Recommendation

More information

Placename CCG. Policies for the Commissioning of Healthcare

Placename CCG. Policies for the Commissioning of Healthcare Placename CCG Policies for the Commissioning of Healthcare Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus. This document is part

More information

Commissioning Statement

Commissioning Statement Commissioning Statement Treatment/ device For the treatment of Commissioning position Flash Glucose Monitoring Systems (including Freestyle Libre ) Monitoring glucose levels in adults and children over

More information

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Version No. Changes Made Version of 05.10.2018 V1 Policy ratified by Healthier

More information

Commissioning Policy

Commissioning Policy Commissioning Policy Abbott FreeStyle Libre Flash Glucose Monitoring System Individual Funding Request Date Adopted: 09 September 2018 Version: 1819.1.02 Title of document: Authors job title(s): Document

More information

Implementation of Freestyle Libre prescribing guidance across the NHS in London

Implementation of Freestyle Libre prescribing guidance across the NHS in London Implementation of FreeStyle Libre prescribing guidance across the NHS in London Contents Section 1 Background to the document (pages 2-5) Section 2 Implementation guidance pathways 1. Recommended implementation

More information

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018. THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial

More information

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who: Advice Statement 009-18 July 2018 Advice Statement What is the clinical and cost effectiveness of Freestyle Libre flash glucose monitoring for patients with diabetes mellitus treated with intensive insulin

More information

medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.

medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre. Pathway for the Managed Access of FreeStyle Libre (Flash Glucose monitoring) for Adults and Children in the care of Trust Specialist Diabetes Clinics in Northern Ireland www.hscboard.hscni.net/download/publications/pharmacy_and_

More information

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age) Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (

More information

FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ

FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ North Central London Joint Formulary Committee FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ GPs should not prescribe FreeStyle Libre sensors on the NHS until

More information

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018) Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018) What is Flash Glucose Monitoring (Flash GM)? Flash glucose monitoring is a small sensor that you wear on your skin (usually

More information

Implementation of Flash Glucose Monitoring

Implementation of Flash Glucose Monitoring Equality Analysis (Health Inequalities, Human Rights, Social Value) Implementation of Flash Glucose Monitoring Before completing this equality analysis it is recommended that you: Contact your equality

More information

Paediatric Diabetes Service Operational Policy

Paediatric Diabetes Service Operational Policy Paediatric Diabetes Service Operational Policy Department / Service: Paediatric Diabetes Service Originator: Dr John Scanlon Diane Cluley PDSN Accountable Director: Dr Andrew Short Approved by: Paediatric

More information

University College Hospital. Blood glucose and HbA 1 c targets

University College Hospital. Blood glucose and HbA 1 c targets University College Hospital Blood glucose and HbA 1 c targets Children & Young People s Diabetes Service The diabetes team at UCLH aims to help every child and young person with Type 1 Diabetes to safely

More information

PUTTING TECHNOLOGY INTO PRACTICE IN THE NHS

PUTTING TECHNOLOGY INTO PRACTICE IN THE NHS PUTTING TECHNOLOGY INTO PRACTICE IN THE NHS Dr Sufyan Hussain MA MB BChir MRCP PhD Locum Consultant Physician in Diabetes and Endocrinology Guy s and St Thomas NHS Foundation Trust On behalf of ABCD DTN-UK

More information

Description of the technology

Description of the technology Advice Note 2017/ 001 What is the clinical effectiveness, safety and budget impact of the Freestyle Libre System compared with current glucose monitoring methods for people aged 4 years and over with diabetes

More information

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus. Children and young people with diabetes mellitus

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus. Children and young people with diabetes mellitus ssociation of Children s Diabetes Clinical Guideline A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in

More information

Placename CCG. Policies for the Commissioning of Healthcare

Placename CCG. Policies for the Commissioning of Healthcare Placename CCG Policies for the Commissioning of Healthcare Policy for the funding of insulin pumps and continuous glucose monitoring devices for patients with diabetes 1 Introduction 1.1 This document

More information

Insulin Pumps and Glucose Monitors in Adults Policy

Insulin Pumps and Glucose Monitors in Adults Policy Insulin Pumps and Glucose Monitors in Adults Policy Version: 2016-19 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 November 2016 NHS Leeds North CCG Governance on Performance and Risk Committee

More information

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the

More information

Clinical News and Innovation in Type 1 Diabetes and Technology. Parth Narendran University Hospitals Birmingham

Clinical News and Innovation in Type 1 Diabetes and Technology. Parth Narendran University Hospitals Birmingham Clinical News and Innovation in Type 1 Diabetes and Technology Parth Narendran University Hospitals Birmingham Adjunctive therapy to insulin Accurate diagnosis of T1D Early intensive treatment Technology

More information

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus

Healthcare professionals involved in care of children and young people with Type 1 Diabetes Mellitus Clinical Guideline A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under

More information

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus

More information

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit:

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit: Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit: To review type 2 diabetic patients prescribed dipedtidylpeptidase-4 (DPP-4) inhibitors (linagliptin (Trajenta, saxagliptin

More information

Commissioning Policy Individual Funding Request

Commissioning Policy Individual Funding Request Commissioning Policy Individual Funding Request Continuous Glucose Monitors Prior Approval Policy Date Adopted: 13 October 2017 Version: 1718.2 Document Control Title of document Continuous Glucose Monitors

More information

Type 1 Diabetes: diagnosis and management. Stakeholder workshop

Type 1 Diabetes: diagnosis and management. Stakeholder workshop Type 1 Diabetes: diagnosis and management Stakeholder workshop 28 th May 2012 Royal College of Paediatrics & Child Health: 5-11 Theobalds Road, London WC1X 8SH Summary notes The stakeholder scoping workshop

More information

Continuous Glucose Monitoring (CGM)/Real-Time Flash Glucose Scanning (FGS) Training for Healthcare Professionals and Patients

Continuous Glucose Monitoring (CGM)/Real-Time Flash Glucose Scanning (FGS) Training for Healthcare Professionals and Patients ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM)/Real-Time Flash Glucose Scanning (FGS) Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents

More information

How effective are national strategies for getting evidence into practice?

How effective are national strategies for getting evidence into practice? How effective are national strategies for getting evidence into practice? Dr Gillian Leng Deputy Chief Executive, NICE Areas to cover Getting NICE guidance into practice Challenges National strategy Impact

More information

NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE PANCREAS ADVISORY GROUP AUDIT OF STANDARD CRITERIA FOR LISTING SUMMARY

NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE PANCREAS ADVISORY GROUP AUDIT OF STANDARD CRITERIA FOR LISTING SUMMARY INTRODUCTION NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE PANCREAS ADVISORY GROUP AUDIT OF STANDARD CRITERIA FOR LISTING SUMMARY 1 Selection criteria for patients onto the national

More information

National Diabetes Insulin Pump Audit, England and Wales

National Diabetes Insulin Pump Audit, England and Wales National Diabetes Insulin Pump Audit, 2016-2017 England and Wales V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA)

More information

Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy

Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy Version: 2017-20 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 November 2016 NHS Leeds North CCG Governance on

More information

How can I access flash glucose monitoring if I need it? Support pack. This pack will help you to find out more about flash and how you can access it.

How can I access flash glucose monitoring if I need it? Support pack. This pack will help you to find out more about flash and how you can access it. How can I access flash glucose monitoring if I need it? Support pack This pack will help you to find out more about flash and how you can access it. Reviewed March 2019 Introduction Following several major

More information

Commissioning for Outcomes in Diabetes. Joanne Taylor Primary Care Commissioning Manager

Commissioning for Outcomes in Diabetes. Joanne Taylor Primary Care Commissioning Manager Commissioning for Outcomes in Diabetes Joanne Taylor Primary Care Commissioning Manager Current Diabetes Model in Dudley History and Current Diabetes Pathway Primary Care 46 2 no LIS practices Annual review

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY APPLICANT (stamp sticker acceptable) Page 1 Fm SA1603 Insulin Pumps INITIAL APPLICATION - permanent neonatal diabetes Applications only from a relevant specialist nurse practitioner. Approvals valid f

More information

National Institute for Health and Care Excellence. Type 2 diabetes. Stakeholder Comments Draft Guideline

National Institute for Health and Care Excellence. Type 2 diabetes. Stakeholder Comments Draft Guideline National Institute for Health and Care Excellence Type 2 diabetes Stakeholder Comments Draft Guideline NOTE: NICE is unable to accept comments from non-registered organisations or individuals. If you wish

More information

Agenda Item 10 - Glucose Monitoring Device for Individuals with Diabetes

Agenda Item 10 - Glucose Monitoring Device for Individuals with Diabetes Dorset Health Scrutiny Committee 17 October 2018 Public Participation Agenda Item 10 - Glucose Monitoring Device for Individuals with Diabetes Questions 1. Rosie and Kirsty Edwardes, Bridport Residents

More information

Community alcohol detoxification in primary care

Community alcohol detoxification in primary care Community alcohol detoxification in primary care 1. Purpose The purpose of this primary care enhanced service is to improve the health and quality of life of people whose health may be compromised by their

More information

National Paediatric Diabetes Audit

National Paediatric Diabetes Audit National Paediatric Diabetes Audit Parent and Carers Report 2015-16 Commissioned by the Healthcare Quality Improvement Partnership Managed by the Royal College of Paediatrics and Child Health National

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Diabetes UK Consensus Guideline for Flash Glucose Monitoring

Diabetes UK Consensus Guideline for Flash Glucose Monitoring Diabetes UK Consensus Guideline for Flash Glucose Monitoring Date published Introduction Our recommendations Overview Who is flash glucose monitoring suitable for? What is the clinical evidence for flash

More information

Acute Stroke - Management of Hyperglycaemia. Contents

Acute Stroke - Management of Hyperglycaemia. Contents Acute Stroke - Management of Hyperglycaemia Classification: Policy Lead Author: Dr Amir Ahmad Additional author(s): Dr Jouher Kallingal, Professor Bob Young, Professor Pippa Tyrrell Authors Division: :

More information

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Aim Review and rationalise the insulin quantities based on dosage instructions for diabetic patients in order to align

More information

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Version Control Version Number Date Amendments made 1 January 2018 1.1 February 2018 Amended to reflect updated SPC advice for sitagliptin

More information

COPYRIGHTED MATERIAL. Chapter 1 An Introduction to Insulin Pump Therapy WHAT IS INSULIN PUMP THERAPY?

COPYRIGHTED MATERIAL. Chapter 1 An Introduction to Insulin Pump Therapy WHAT IS INSULIN PUMP THERAPY? Chapter 1 An Introduction to Insulin Pump Therapy This chapter will provide information on what insulin pump therapy is, and how insulin pumps have developed from the early models introduced in the 1970s

More information

New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people

New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people Article New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people Helen Thornton This is the first of two articles on the 2015 NICE NG18 guideline,

More information

Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services?

Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services? Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services? Dr PARIJAT DE DUK Clinical Champion Clinical Lead for Diabetes & Endocrinology, Sandwell & West

More information

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines

More information

BEST PRACTICE GUIDE: Continuous subcutaneous insulin infusion (CSII) - A guide to service requirements

BEST PRACTICE GUIDE: Continuous subcutaneous insulin infusion (CSII) - A guide to service requirements BEST PRACTICE GUIDE: Continuous subcutaneous insulin infusion (CSII) - A guide to service requirements 02 BEST PRACTICE GUIDE CONTENTS Page Contributors 4 Foreword 5 Objectives 6 Introduction 6 Insulin

More information

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not routinely offered for adults with type 2 diabetes

More information

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Introduction The Integrated Community Diabetes Service (ICDS) will deliver high quality care to individuals who

More information

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) June 2017 Review: June 2020 (earlier if required see recommendations) Bulletin 255: Insulin aspart New Formulation - Fiasp JPC Recommendations:

More information

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care Technical guidance NHS England INFORMATION READER BOX Directorate

More information

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG Shaping Diabetes Services in Southern Derbyshire A vision for Diabetes Services For Southern Derbyshire CCG Vanessa Vale Commissioning Manager September 2013 Contents 1. Introduction 3 2. National Guidance

More information

Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim

Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine Conflict of interest

More information

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young

More information

National Diabetes Audit Programme Update LONDON REGION DIABETES EVENT 18 JULY 2017

National Diabetes Audit Programme Update LONDON REGION DIABETES EVENT 18 JULY 2017 National Diabetes Audit Programme Update LONDON REGION DIABETES EVENT 18 JULY 2017 NDA Reports NDA Insulin Pump Audit 2015-16 NDA Complications and Mortality 2015-16: Standard analysis Longitudinal analysis

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES Generic Brand HICL GCN Exception/Other BLOOD SUGAR DIAGNOSTIC DIABETIC TEST STRIPS 25200 NOTE: Requests for preferred blood glucose (diabetic) test strips manufactured by Abbott Diabetes Care (such as

More information

Improving Diabetes Care The role of the integrated diabetes network. Ian Gallen Royal Berkshire Hospital

Improving Diabetes Care The role of the integrated diabetes network. Ian Gallen Royal Berkshire Hospital Improving Diabetes Care The role of the integrated diabetes network Ian Gallen Royal Berkshire Hospital Need for Change? National Diabetes now accounts for >12% NHS spend and is rising Increasing incidence,

More information

CONTINUOUS OR INTERMITTENT GLUCOSE MONITORING IN INTERSTITIAL FLUID

CONTINUOUS OR INTERMITTENT GLUCOSE MONITORING IN INTERSTITIAL FLUID FLUID Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent

More information

Networking for success: A burning platform in Berkshire West

Networking for success: A burning platform in Berkshire West SERVICE REDESIGN CASE STUDY 1: NOVEMBER 2014 Networking for success: A burning platform in Berkshire West SUMMARY In 2012, four federated CCGs set up a network to redesign diabetes services in Berkshire

More information

Diabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust

Diabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending

More information

Senior Nurse. (Diabetes)

Senior Nurse. (Diabetes) Annual C onference 6 th Novem mber 2008 Royal Court Hotel, Coventry Pre-assessment and the patient with diabetes. Louise Hilton Senior Nurse (Diabetes) BoltonPCT PCT. Bolton. Introdu uction. Diabetes

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus This guidance was issued in

More information

Hypoglycaemia in the community

Hypoglycaemia in the community Hypoglycaemia in the community Using local data to monitor the quality of diabetes services Adrian R Scott 11 th April 2008 Sheffield Teaching Hospitals NHS Foundation Trust DCCT: the price of improved

More information

Information leaflet for MDI patients. Improving Diabetes using Diasend

Information leaflet for MDI patients. Improving Diabetes using Diasend Information leaflet for MDI patients Improving Diabetes using Diasend Contents Easy Steps for Setting up Diasend Account 2 Finding the resources on the internet 3 VIP Patient Diasend Assessment Template

More information

Country Health SA Local Health Network. Title: Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) Ambulatory Service

Country Health SA Local Health Network. Title: Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) Ambulatory Service Protocol (Clinical) Title: Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) Ambulatory Service Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor: CHSALHN, Executive

More information

Diabetes education: the big missed opportunity in diabetes care? Phaedra Perry Regional Head South West Katherine Calder Senior Policy Officer

Diabetes education: the big missed opportunity in diabetes care? Phaedra Perry Regional Head South West Katherine Calder Senior Policy Officer Diabetes education: the big missed opportunity in diabetes care? Phaedra Perry Regional Head South West Katherine Calder Senior Policy Officer What is diabetes self-management education? A menu of education

More information

Examples of Reflection / Learning Outcomes

Examples of Reflection / Learning Outcomes Examples of Clinician Reflection Now responding to patient s blood glucose record more respectfully and asking patient for permission before giving advice. Helping client to brainstorm their own solutions

More information

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not be routinely offered for adults with type 2 diabetes

More information

Livongo for Diabetes Program: Frequently Asked Questions

Livongo for Diabetes Program: Frequently Asked Questions Livongo for Diabetes Program: Frequently Asked Questions WHO IS ELIGIBLE FOR THE LIVONGO PROGRAM? BorgWarner U.S. employees and their eligible dependents who are enrolled in any BorgWarner Medical Plan

More information

the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and

the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and Exenatide (Byetta) and Liraglutide (Victoza) prescribing guidance: Notes for initiation in primary care These incretin mimetics are given by subcutaneous injection once or twice daily. They have similar

More information

Walsall CCG Supported Blood Glucose Meters April 2018

Walsall CCG Supported Blood Glucose Meters April 2018 Meter Name Picture Type Strips Lancets Information Company PRIMARY CARE INITIATION TEE2+ Uncomplicated Type 2 diabetes patient on TEE2 test CareSens Lancets Easy to use. Large clear display Bluetooth functionality

More information

DATE RECEIVED 09/10/2017 SUBJECT Formulary PASSED TO Mary DATE PASSED 09/10/2017 RESPOND BY 27/10/2017 CATEGORY Business FoI NUMBER

DATE RECEIVED 09/10/2017 SUBJECT Formulary PASSED TO Mary DATE PASSED 09/10/2017 RESPOND BY 27/10/2017 CATEGORY Business FoI NUMBER DATE RECEIVED 09/10/2017 SUBJECT Formulary PASSED TO Mary DATE PASSED 09/10/2017 RESPOND BY 27/10/2017 CATEGORY Business FoI NUMBER 2017-404 Question/s to be Answered Can you please provide the following

More information

QOF Indicator DM013:

QOF Indicator DM013: QOF Indicator DM013: The percentage of patients with diabetes, on the register, who have a record of a dietary review by a suitably competent professional in the preceding 12 months Note: the bold signposts

More information

Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting

Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting Practice Baseline Questionnaire/Practice development plan for Consultant/DSN meeting Name of Practice Contact details of practice staff who you would like a copy of this questionnaire to be sent to when

More information

The Practice of Delivering Diabetes Medicines Optimisation. Elizabeth Hackett Principal Pharmacist for Diabetes

The Practice of Delivering Diabetes Medicines Optimisation. Elizabeth Hackett Principal Pharmacist for Diabetes The Practice of Delivering Diabetes Medicines Optimisation Elizabeth Hackett Principal Pharmacist for Diabetes University i Hospitals Leicester Agenda Background (NaDIA and local data) Challenges facing

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Gestational diabetes: risk assessment, testing, diagnosis and management bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

Priorities Advisory Committee

Priorities Advisory Committee Insulin degludec (Tresiba ) PAC - Insulin degludec (Tresiba ) 2.1 The East of England Priorities Advisory Committee A function of GUIDANCE STATEMENT PAC Recommendations 1. Insulin degludec is NOT recommended

More information

NHS Greater Glasgow and Clyde Adult Blood Glucose Meter and Test Strip Formulary

NHS Greater Glasgow and Clyde Adult Blood Glucose Meter and Test Strip Formulary NHS Greater Glasgow and Clyde Adult Blood Glucose and Test Strip Formulary 2016-17 Primary Care and Acute Joint Formulary Blood Glucose formulary developed by the Diabetes MCN Blood Glucose Formulary Review

More information

PUBLIC PETITIONS COMMITTEE AGENDA. 2nd Meeting, 2019 (Session 5) Thursday 24 January 2019

PUBLIC PETITIONS COMMITTEE AGENDA. 2nd Meeting, 2019 (Session 5) Thursday 24 January 2019 PPC/S5/19/2/A PUBLIC PETITIONS COMMITTEE AGENDA 2nd Meeting, 2019 (Session 5) Thursday 24 January 2019 The Committee will meet at 9.00 am in the Mary Fairfax Somerville Room (CR2). 1. Consideration of

More information

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk

More information

Diabetes in England NHS Medical Directorate. Dr Rowan Hillson MBE National Clinical Director for Diabetes

Diabetes in England NHS Medical Directorate. Dr Rowan Hillson MBE National Clinical Director for Diabetes Diabetes in England 2010 Dr Rowan Hillson MBE National Clinical Director for Diabetes I strongly believe that Everyone with diabetes deserves the highest standards of personalised diabetes care, no matter

More information

SFHDiabIPT01. Assess the suitability of insulin pump therapy for an individual with Type 1 diabetes. Overview

SFHDiabIPT01. Assess the suitability of insulin pump therapy for an individual with Type 1 diabetes. Overview Assess the suitability of insulin pump therapy for an individual with Type Overview This standard covers the activities associated with assessing the suitability of insulin pump therapy for individuals

More information

Type 2 Diabetes Recommended SMBG

Type 2 Diabetes Recommended SMBG Herefordshire Diabetes Guideline for Self-Monitoring Blood Glucose (SMBG) Type 2 Diabetes Recommended SMBG Diet controlled/ metformin only/ combination of metformin and pioglitazone/dpp4/sglt2 or GLP1

More information

PATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS

PATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS PATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS November 2009 Orlistat PGD Page 1 of 7 Rationale Patient Group Direction For Supply Of Orlistat By Community Pharmacists To enable

More information

Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes. Elena Toschi, MD November 12, 2016

Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes. Elena Toschi, MD November 12, 2016 Update on Continuous Glucose Monitoring (CGM) Technology in Diabetes Elena Toschi, MD November 12, 2016 Presenter Disclosure Information Elena Toschi, MD No financial disclosure Objectives: Use of CGM

More information

Regional Medicines Optimisation Committee (North)

Regional Medicines Optimisation Committee (North) Present: Regional Medicines Optimisation Committee (North) October 26 th 2017 Minutes Quarry House, Leeds 10:00-1:00 pm Name Title Organisation Jun Oct Dr Mike Prentice (MP) Chair Michele Cossey (MC) Dr

More information

BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI

BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI CASE AUTH/2638/9/13 and AUTH/2639/9/13 BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI Promotion of Lyxumia Bristol-Myers Squibb and AstraZeneca jointly complained about cost comparison claims in a Lyxumia

More information

The Association of British Clinical Diabetologists (ABCD) Clinical Audit Programme

The Association of British Clinical Diabetologists (ABCD) Clinical Audit Programme The Association of British Clinical Diabetologists (ABCD) Clinical Audit Programme 2009-10 An audit of Inpatient Diabetes Care across NHS Lothian; The effectiveness of the use of information technology,

More information

Service Specification. Diabetes Integrated Service NHS Southern Derbyshire CCG

Service Specification. Diabetes Integrated Service NHS Southern Derbyshire CCG Service Specification Diabetes Integrated Service NHS Southern Derbyshire CCG DRAFT: Version 8 27 th May 2014 Contents 1. Population Needs... 2 1.1 National/local context and evidence base... 2 2. Outcomes...

More information

DIABETES PATIENT STRATIFICATION AND TESTING SAVING MONEY, SAVING LIVES

DIABETES PATIENT STRATIFICATION AND TESTING SAVING MONEY, SAVING LIVES DIABETES PATIENT STRATIFICATION AND TESTING SAVING MONEY, SAVING LIVES Contents 2 The Rising Cost of Diabetes 5 Implementation 3 P atient Stratification is the Key to Saving Lives and Money 6 M eeting

More information

Management of adults with diabetes undergoing surgery and elective procedures: Improving standards

Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Revised September 2015 Changes in the second edition of the peri-operative document Preoperative pathway

More information

National Peer Review Report: Wales Paediatric Diabetes 2014

National Peer Review Report: Wales Paediatric Diabetes 2014 National Peer Review Report: Wales Paediatric Diabetes 2014 An overview of the findings from the 2014 National Peer Review of Paediatric Diabetes Services in Wales 1 Contents 1.0 Introduction... 3 1.1

More information